Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristian Brock

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Eye (London, England)|January 11, 2024
Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial HypertensionOlivia Grech, James L Mitchell, Hannah S Lyons, et al.
Translational Vision Science & Technology|May 1, 2023
Visual Field Pointwise Analysis of the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT)Susan P Mollan, Samuel Bodoza, Áine Ní Mhéalóid, et al.
Plos One|July 11, 2024
A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trialVenkataramanan Srinivasan, Victoria Homer, Darren Barton, et al.
Headache|January 24, 2025
A randomized sequential cross-over trial evaluating five purportedly ICP-lowering drugs in idiopathic intracranial hypertensionJames L Mitchell, Hannah S Lyons, Jessica K Walker, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 21, 2022
A Critical Investigation of Cerebellar Associative Learning in Isolated DystoniaAnna Sadnicka, Lorenzo Rocchi, Anna Latorre, et al.
The Lancet. Respiratory Medicine|March 23, 2020
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trialGary Middleton, Kristian Brock, Joshua Savage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2019
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid LeukemiaCharles Craddock, Daniel Slade, Carmela De Santo, et al.
Brain : a Journal of Neurology|March 12, 2023
The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trialJames L Mitchell, Hannah S Lyons, Jessica K Walker, et al.
BMC Medical Research Methodology|January 20, 2019
How to design a dose-finding study using the continual reassessment methodGraham M Wheeler, Adrian P Mander, Alun Bedding, et al.
JAMA Ophthalmology|October 22, 2020
Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial HypertensionVivek Vijay, Susan P Mollan, James L Mitchell, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Eye (London, England)|January 11, 2024
Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial HypertensionOlivia Grech, James L Mitchell, Hannah S Lyons, et al.
Translational Vision Science & Technology|May 1, 2023
Visual Field Pointwise Analysis of the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT)Susan P Mollan, Samuel Bodoza, Áine Ní Mhéalóid, et al.
Plos One|July 11, 2024
A low molecular weight dextran sulphate, ILB®, for the treatment of amyotrophic lateral sclerosis (ALS): An open-label, single-arm, single-centre, phase II trialVenkataramanan Srinivasan, Victoria Homer, Darren Barton, et al.
Headache|January 24, 2025
A randomized sequential cross-over trial evaluating five purportedly ICP-lowering drugs in idiopathic intracranial hypertensionJames L Mitchell, Hannah S Lyons, Jessica K Walker, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 21, 2022
A Critical Investigation of Cerebellar Associative Learning in Isolated DystoniaAnna Sadnicka, Lorenzo Rocchi, Anna Latorre, et al.
The Lancet. Respiratory Medicine|March 23, 2020
Pembrolizumab in patients with non-small-cell lung cancer of performance status 2 (PePS2): a single arm, phase 2 trialGary Middleton, Kristian Brock, Joshua Savage, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2019
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid LeukemiaCharles Craddock, Daniel Slade, Carmela De Santo, et al.
Brain : a Journal of Neurology|March 12, 2023
The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trialJames L Mitchell, Hannah S Lyons, Jessica K Walker, et al.
BMC Medical Research Methodology|January 20, 2019
How to design a dose-finding study using the continual reassessment methodGraham M Wheeler, Adrian P Mander, Alun Bedding, et al.
JAMA Ophthalmology|October 22, 2020
Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial HypertensionVivek Vijay, Susan P Mollan, James L Mitchell, et al.
Pageof 4